HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
Gastrointestinal carcinoid tumors are a type of rare neuroendocrine tumor that originates in the gastrointestinal tract, particularly in the stomach, small intestine, appendix, and rectum. These tumors arise from neuroendocrine cells, which are specialized cells that produce hormones to regulate various bodily functions. Unlike other types of gastrointestinal tumors, carcinoid tumors tend to grow slowly and may not cause noticeable symptoms in the early stages. As the tumor progresses, symptoms may include abdominal pain, diarrhea, flushing of the skin, and, in some cases, carcinoid syndrome, characterized by a group of symptoms such as facial flushing, diarrhea, and difficulty breathing. Diagnosis often involves imaging studies such as CT scans, MRIs, and endoscopies, along with blood tests to measure levels of specific hormones produced by the tumorSurgical removal is a common approach, and in some cases, medications may be prescribed to control symptoms and inhibit tumor growth. Prognosis varies depending on factors such as the size of the tumor, its location, and whether it has spread to other parts of the body. Overall, the prognosis for gastrointestinal carcinoid tumors is generally favorable, especially when detected and treated in the early stages.
